Search clinical trials for: Protopic® (Tacrolimus) 0.1% ointment

Total 768 results

Kim, Seoung-Hoon
Astellas Pharma Korea, Inc.; Linical Korea

Completed

To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

Liver Transplantation
Alcon Research

Completed

Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects

Dry Eye
Healthpoint

Withdrawn

Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home Setting

Partial Thickness Wounds
European Egyptian Pharmaceutical Industries

Terminated

Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (PED111)

Diabetic Foot Ulcer

Egypt
Photocure

Completed

Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia

Cervical Intraepithelial Neoplasia

Norway, Germany
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Completed

PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION

Kidney Failure, Acute

Switzerland, Italy
University of Peradeniya

Completed

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

Oral Lichen Planus
Georgetown University

Terminated

Envarsus XR in African American Renal Transplant Recipients (EXR)

Renal Transplant Recipients

United States
Sandoz

Withdrawn

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. (TODAY)

Kidney Transplant

France, Germany
UMC Utrecht

Completed

Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

Atopic Dermatitis

Netherlands
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

Optimizing Prograf® Therapy in Renal Transplant Patients (OPTIMA)

Renal Transplantation

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

Hepatitis B

Italy
Aucta Pharmaceuticals, Inc

Terminated

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Tuberous Sclerosis | Angiofibroma of Face

United States, China
Southern Medical University, China
First Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern...

Not yet recruiting

Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation

Liver Transplantation

China
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Opera CRO, a TIGERMED Group Company

Completed

Hyaluronic Acid and Gingivitis in Pediatrics

Gingivitis
Clinical Research Center of the Carolinas
Pfizer

Completed

Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period

Atopic Dermatitis

United States
Allergan

Completed

A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Alcon Research

Completed

Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION

Dry Eye
Allergan

Completed

Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

Dry Eye Syndromes

Germany
Barbara Ann Karmanos Cancer Institute

Completed

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Hematological Malignancies

United States
Andrew Meltzer
BioMérieux

Completed

Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway (URGENT)

Acute Respiratory Infection | Viral Infection | Upper Resp Tract Infection

United States
H. Lee Moffitt Cancer Center and Research Institute
Gateway for Cancer Research

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (Ustekinumab)

Graft vs. Host Disease

United States
Actavis Inc.

Completed

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Healthy

United States
Chiesi Farmaceutici S.p.A.

Completed

Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients (STEADY)

End Stage Renal Disease

Italy
Prove pharm

Not yet recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients

Ureter Injury
Galderma R&D

Completed

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

No longer available

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Secondary Myelofibrosis

United States
Alcon Research

Completed

Nepafenac 0.3% Two Study

Cataract

United States
Novartis Pharmaceuticals

Completed

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients (SIMCER)

Liver Transplantation

France
Hospices Civils de Lyon

Completed

Priming of Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 or Sodium Chloride 0.9% : Pilot Study in Adult Elective Conventional Cardiac Surgery (OPTIMUS-PRIME)

Cardiac Surgery | Extracorporeal Circulation

France
Galderma R&D

Completed

Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins

Healthy Skin

Singapore
Pfizer

Completed

A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test

Psoriasis

Germany
Astellas Pharma Inc

Completed

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

Kidney Transplantation

United States, Canada
Yonsei University

Completed

Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients

Kidney Transplant Patients

Korea, Republic of
Allergan

Completed

A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye

Dry Eye Syndromes | Keratoconjunctivitis Sicca

France, United Kingdom
Galderma R&D

Completed

Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis

Plaque Psoriasis

United States, Canada
The Catholic University of Korea

Unknown

Effect of Postoperative Ferric Carboxymaltose

Knee Osteoarthritis | Total Knee Arthroplasty | Postoperative Anemia
The Catholic University of Korea

Unknown

Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty

Knee Osteoarthritis | Total Knee Arthroplasty | Postoperative Anemia
Stefan Schieke MD

Withdrawn

Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Cutaneous T-cell Lymphoma (CTCL)

United States
Hospital General Universitario Elche

Completed

Glyceryl Trinitrate Ointment vs Posterior Tibial Nerve Stimulation in the Treatment of Anal Fissure

Pain
Birken AG

Completed

Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds

Burns

Switzerland, Sweden, United Kingdom, Germany
Hospital Clinico Universitario de Santiago
Fundación Ramón Domínguez

Completed

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) (GRC)

Thyroid Eye Disease | Thyroid Associated Ophthalmopathies | Graves´ Ophthalmopathy

Spain
Allergan

Completed

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Ocular Hypertension | Glaucoma, Open-Angle

Korea, Republic of
Fresenius Kabi Japan

Completed

Trial of 6% HES130/0.4

Hemorrhage | Hypovolemia

Japan
Allergan

Completed

A Study of Bimatoprost 0.01% in the Clinical Setting (APPEAL-Taiwan)

Ocular Hypertension | Glaucoma, Primary Open Angle

Taiwan
GlaxoSmithKline

Completed

Bioequivalence - Duodart Against Avodart & Omnic

Prostatic Hyperplasia

Russian Federation
Alcon Research

Completed

Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects

Allergic Conjunctivitis
Astellas Pharma Inc

Completed

A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure (CRAF)

Kidney Transplantation | Graft Rejection

United States
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

Organ or Tissue Transplant; Complications

France

3

Subscribe